TL, B., PD, S., I, A., CE, W., DW, R., SC, B., . . . N, D. (2024). Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 23(6), 1163. https://doi.org/10.1016/j.jcf.2024.04.009
Chicago Style (17th ed.) CitationTL, Blake, Sly PD, Andersen I, Wainwright CE, Reid DW, Bell SC, Smith BR, Kettle AJ, and Dickerhof N. "Changes in Urinary Glutathione Sulfonamide (GSA) Levels Between Admission and Discharge of Patients with Cystic Fibrosis." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 23, no. 6 (2024): 1163. https://doi.org/10.1016/j.jcf.2024.04.009.
MLA (9th ed.) CitationTL, Blake, et al. "Changes in Urinary Glutathione Sulfonamide (GSA) Levels Between Admission and Discharge of Patients with Cystic Fibrosis." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 23, no. 6, 2024, p. 1163, https://doi.org/10.1016/j.jcf.2024.04.009.